Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.1B | 3.7B | 3.0B | 2.7B |
Cost of revenue | 2.1B | 2.6B | 2.1B | 1.9B |
Gross profit | 965.7M | 1.1B | 896.5M | 809.4M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 276.4M | 264.2M | 268.4M | 186.5M |
Operating income | 306.7M | 402.8M | 271.5M | 289.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 52.0M | 51.7M | 45.5M | 45.3M |
Other income expense | — | — | — | — |
Pretax income | 301.5M | 406.1M | 286.4M | 306.7M |
Tax provision | 74.0M | 111.3M | 73.9M | 78.7M |
Net income | 227.5M | 294.9M | 212.5M | 228.0M |
Basic EPS | — | 12.1 | 8.7 | 9.3 |
Diluted EPS | — | 12.1 | 8.7 | 9.3 |
Basic average shares | — | 24.5M | 24.5M | 24.5M |
Diluted average shares | — | 24.5M | 24.5M | 24.5M |
EBITDA | 522.8M | 625.3M | 481.8M | 495.2M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |